MRVI stock news

MRVI stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

7 wire items

2026-09-29 20:01:00 UTC#387064newconfirmednews

Maravai LifeSciences subsidiary TriLink receives second CleanCap patent in China for cap analogs

tradingviewimportance 0.40trust 0.70Maravai LifeSciences Holdings, Inc. +0.40TriLink BioTechnologies, Inc. +0.40CleanCap +0.40+1 entities

2026-08-07 10:25:17 UTC#144049newconfirmednews

Maravai LifeSciences issues 2026 adjusted EBITDA outlook of $33M-$35M, maintains $205M-$215M revenue guidance

seeking alphaimportance 0.50trust 0.70Maravai LifeSciences Holdings, Inc. +0.20

2026-08-07 10:21:28 UTC#144048newconfirmednews

Maravai LifeSciences Holdings average analyst price target raised to $6.50, implying 4% upside

tradingviewimportance 0.30trust 0.70Maravai LifeSciences Holdings, Inc. +0.20

2026-08-07 03:32:58 UTC#142140newconfirmedpress release

Maravai LifeSciences Holdings, Inc. (MRVI) releases 2026 Q2 earnings presentation

seeking alphaimportance 0.40trust 0.80Maravai LifeSciences Holdings, Inc. 0

2026-08-06 23:10:07 UTC#141184updateconfirmednews

Maravai LifeSciences (MRVI) Q2 results show 9% revenue growth driven by TriLink and Cygnus segments

quartrimportance 0.40trust 0.60Maravai LifeSciences Holdings, Inc. +0.40TriLink Biotechnologies +0.50Cygnus Technologies +0.30

2026-08-06 20:06:47 UTC#139953newconfirmednews

Maravai LifeSciences Holdings Q2 Non-GAAP EPS -$0.02 beats by $0.02, Revenue $51.4M beats by $2.72M

seeking alphaimportance 0.40trust 0.80Maravai LifeSciences Holdings, Inc. +0.40

2026-08-04 22:43:11 UTC#126355newconfirmednews

Maravai LifeSciences Q2 2026 Earnings Preview: Analysts Forecast $0.04 Loss and $48.68M Revenue

reutersimportance 0.30trust 0.90Maravai LifeSciences Holdings, Inc. -0.10London Stock Exchange Group plc 0